Contact this trialFirst, we need to learn more about you.
Hormone Therapy
GDC-9545 + Palbociclib/LHRH Agonist for Breast Cancer
Recruiting1 awardPhase 1
New York, New York
This trial will study the safety and effectiveness of the drug GDC-9545 as a treatment for people with a certain type of breast cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.